네트워크 약리학을 통한 당뇨병성 신병증에서의 황기와 산수유의 활성 성분 및 잠재 타겟 예측
Network Pharmacology: Prediction of Astragalus Membranaceus’ and Cornus Officinalis’ Active Ingredients and Potential Targets to Diabetic Nephropathy
1
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
The purpose of this study is to predict the effects of macroscopic and integrative therapies by finding active ingredients, potential targets of Astragalus membranaceus (Am) and Cornus officinalis (Co) for diabetic nephropathy. We have constructed network pharmacology-based systematic and network methodology by system biology, chemical structure, chemogenomics. We found several active ingredients of Astragalus membranaceus (Am) and Cornus officinalis (Co) that were speculated to bind to specific receptors which had been known to have a role in the progression of diabetic nephropathy. Four components of Am and eleven components of Co could bind to iNOS; two ingredients of Am and six ingredients of Co could docking to cGB-PDE; one component of Am and nine components of Co could bind to ACE; three ingredients of Co with neprilysin; three components of Co with ET-1 receptor; four ingredients of Am and fourteen ingredients of Co with mineralocorticoid receptor; one component of Am and seven components of Co with interstitial collagenase; one ingredient of Am and ten ingredients of Co with membrane primary amine oxidase; one component of Am and four components of Co with JAK2; two ingredients of Am and one ingredient of Co with MAPK 12; one component of Am and five components of Co could docking to TGF-beta receptor type-1. From this work we could speculate that the possible mechanisms of Am and Co for diabetic nephropathy are anti-inflammatory, antioxidant and antihypertensive effects.
Abstract
The purpose of this study is to predict the effects of macroscopic and integrative therapies by finding active ingredients, potential targets of Astragalus membranaceus (Am) and Cornus officinalis (Co) for diabetic nephropathy. We have constructed network pharmacology-based systematic and network methodology by system biology, chemical structure, chemogenomics. We found several active ingredients of Astragalus membranaceus (Am) and Cornus officinalis (Co) that were speculated to bind to specific receptors which had been known to have a role in the progression of diabetic nephropathy. Four components of Am and eleven components of Co could bind to iNOS; two ingredients of Am and six ingredients of Co could docking to cGB-PDE; one component of Am and nine components of Co could bind to ACE; three ingredients of Co with neprilysin; three components of Co with ET-1 receptor; four ingredients of Am and fourteen ingredients of Co with mineralocorticoid receptor; one component of Am and seven components of Co with interstitial collagenase; one ingredient of Am and ten ingredients of Co with membrane primary amine oxidase; one component of Am and four components of Co with JAK2; two ingredients of Am and one ingredient of Co with MAPK 12; one component of Am and five components of Co could docking to TGF-beta receptor type-1. From this work we could speculate that the possible mechanisms of Am and Co for diabetic nephropathy are anti-inflammatory, antioxidant and antihypertensive effects.
참고문헌 (29)
- The Korean Society of Nephrology, "Clinical Nephrology" (2005), The Korean Society of Nephrology
- 김동훈, "三七根이 당뇨병성 신병증에 미치는 영향", 박사, 한의학과, pp.2013
- 황상문, "중국 네트워크약리학 데이터베이스 구축 현황 및 TCMSP의 활용가능성 검토 - 사상체질의학의 약물을 중심으로 -", 동의생리병리학회지, 29(6), pp.443~450 (2015), 한의병리학회[DOI]
- Zhang HW, "Astragalus (a traditional Chinese medicine) for treating chronic kidney disease", The Cochrane database of systematic reviews, (10), pp.CD008369~ (2004)
- Hsu PC, "Integrating traditional Chinese medicine healthcare into diabetes care by reducing the risk of developing kidney failure among type 2 diabetic patients : a population-based case control study", Journal of ethnopharmacology, 156, pp.358~364 (2014)
- Nemeth K, "Deglycosylation by small intestinal epithelial cell beta-glucosidases is a critical step in the absorption and metabolism of dietary flavonoid glycosides in humans", European journal of nutrition, 42(1), pp.29~42 (2003)
- Lipinski CA, "Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings", Advanced drug delivery reviews, 46(1-3), pp.3~26 (2001)
- Yu H, "A systematic prediction of multiple drug-target interactions from chemical, genomic, and pharmacological data", PloS one, 7(5), pp.e37608~ (2012)
- Livingstone DJ, "Drug Design Strategies: Quantitative Approaches" (2011), Royal Society of Chemistry
- Zhou W, "Systems Pharmacology in Small Molecular Drug Discovery", International journal of molecular sciences, 17(2), pp.246~ (2016)
- Li S, "Traditional Chinese medicine network pharmacology : theory, methodology and application", Chinese journal of natural medicines, 11(2), pp.110~120 (2013)
- Yang M, "Navigating traditional chinese medicine network pharmacology and computational tools", Evidence-based complementary and alternative medicine : eCAM, 2013, pp.731969~ (2013)
- Lee KH, "A patient with minimal change disease and acute focal tubulointerstitial nephritis due to traditional medicine : a case report and small literature review", Explore, 10(5), pp.319~323 (2014)
- "Prediction of Drug-Like Properties" (2000)[URL]
- Tao W, "Network pharmacology-based prediction of the active ingredients and potential targets of Chinese herbal Radix Curcumae formula for application to cardiovascular disease", Journal of ethnopharmacology, 145(1), pp.1~10 (2013)
- Liebeschuetz JW, "Pose prediction and virtual screening performance of GOLD scoring functions in a standardized test", Journal of computer-aided molecular design, 26(6), pp.737~748 (2012)
- Sharma V, "Role of Different Molecular Pathways in the Development of Diabetes- Induced Nephropathy", J Diabetes Metab, S9(004) (2013)
- Chang PC, "Advanced glycosylation end products induce inducible nitric oxide synthase(iNOS)expression via a p38 MAPK-dependent pathway", Kidney international, 65(5), pp.1664~1675 (2004)
- Sasser JM, "Endothelin A receptor blockade reduces diabetic renal injury via an anti-inflammatory mechanism", Journal of the American Society of Nephrology : JASN, 18(1), pp.143~154 (2007)
- Simonson MS, "Endothelin-1 increases collagen accumulation in renal mesangial cells by stimulating a chemokine and cytokine autocrine signaling loop", The Journal of biological chemistry, 286(13), pp.11003~11008 (2011)
- Bae EH, "Renoprotective effects of sildenafil in DOCA-salt hypertensive rats", Kidney & blood pressure research, 36(1), pp.248~257 (2012)
- Shibata S, "Mineralocorticoid receptor as a therapeutic target in chronic kidney disease and hypertension", Hypertension research : official journal of the Japanese Society of Hypertension (2016)
- Stolen CM, "Semicarbazide sensitive amine oxidase overexpression has dual consequences : insulin mimicry and diabetes-like complications", FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 18(6), pp.702~704 (2004)
- Zhao TT, "Chaihuang-Yishen granule inhibits diabetic kidney disease in rats through blocking TGF-beta", Smad3 signaling, 2014, pp.9(3), e90807~
- Verbeke M, "Beneficial effect of serotonin 5-HT2-receptor antagonism on renal blood flow autoregulation in cyclosporin-treated rats", Journal of the American Society of Nephrology : JASN, 10(1), pp.28~34 (1999)
- Yamada K, "Serotonin potentiates high-glucose-induced endothelial injury : the role of serotonin and 5-HT(2A)receptors in promoting thrombosis in diabetes", Journal of pharmacological sciences, 119(3), pp.243~250 (2012)
- Kobayashi S, "Blockade of serotonin 2A receptor improves glomerular endothelial function in rats with streptozotocin-induced diabetic nephropathy", Clinical and experimental nephrology, 12(2), pp.119~125 (2008)
- Kanwar YS, "Diabetic nephropathy : mechanisms of renal disease progression", Experimental biology and medicine, 233(1), pp.4~11 (2008)
- Shin MK, "Clinical Herbology" (1986), Younglimsa